Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...

Unexpectedly catapulted into global fame as a COVID-19 vaccine maker, BioNTech is on the verge of returning to its oncology ...

CLAIM: Video shows that the CEO of BioNTech, Dr. Ugur Sahin, will not take the COVID-19 vaccine that his firm developed with Pfizer. THE FACTS: Social media posts are misrepresenting an interview that ...

BioNTech’s oncology strategy centers on a bispecific antibody that the company envisions as the backbone of many potential drug combinations for many types of cancer. Bristol Myer Squibb is buying ...